Montpharma SRL
Montpharma reported total assets of 135,487 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Mar 2026).
The score of Montpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Montpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Mar 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
Montpharma's financial analysis
- Solvency82.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Montpharma
Montpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1003.738.776
- VAT number
- BE1003738776
- Peppol
- Registered · 0208:1003738776 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 2023
- Registered office
- 1190 Forest
- Latest accounts
- 2025 · filed on 05 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Montpharma (SRL) has been based in Forest since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 41,561 € and equity of 111,460 €; its revenue is not published. Its solvency stands at 82.3%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Montpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek de Scheerder Retail sale of pharmaceutical products Ghent · balance sheet 128,527 €
- Pharmacie Severin Retail sale of pharmaceutical products Sambreville · balance sheet 243,411 €
- Phardep Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 117,517 €
- Jeûne & Hormèse Retail sale of pharmaceutical products Chaudfontaine · balance sheet 27,054 €
- Somad Retail sale of pharmaceutical products Frameries · balance sheet 170,686 €
- Caroline Vandierendonck Retail sale of pharmaceutical products Bree · balance sheet 115,934 €
- Charlie Retail sale of pharmaceutical products Retie · balance sheet 106,397 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
Frequently asked questions about Montpharma
What is the revenue of Montpharma?
Montpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Montpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1003738776 for Montpharma, if the company is VAT-registered. Its company number (CBE) is 1003.738.776.
Where is the registered office of Montpharma?
According to the CBE register, the registered office of Montpharma is in 1190 Forest.
What is the equity of Montpharma?
At the close of the 2025 financial year, the equity of Montpharma amounts to 111,460 €, a solvency of 82.3% of total assets.
Who manages Montpharma?
The register lists 2 active mandates at Montpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Montpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →